Cargando…

Reply: COVID-19 drug research and the cohort multiple randomised controlled trial design

The use of cohort multiple randomised controlled trials and epidemic crises https://bit.ly/39Obd4N

Detalles Bibliográficos
Autores principales:	Porcher, Raphaël, Ravaud, Philippe, Resche-Rigon, Matthieu, Tharaux, Pierre-Louis, Mariette, Xavier, Hermine, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353064/ https://www.ncbi.nlm.nih.gov/pubmed/35896213 http://dx.doi.org/10.1183/13993003.01187-2022

Ejemplares similares

Effect of interleukin-6 receptor antagonists in critically ill adult patients with COVID-19 pneumonia: two randomised controlled trials of the CORIMUNO-19 Collaborative Group
por: Hermine, Olivier, et al.
Publicado: (2022)

Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial
por: Lacombe, Karine, et al.
Publicado: (2023)

COVID-19 drug research and the cohort multiple randomised controlled trial design
por: Dal-Ré, Rafael
Publicado: (2022)

Reply: Confounding in Mendelian randomisation studies
por: Reynolds, Carl J., et al.
Publicado: (2023)

Combining multiple imputation and meta-analysis with individual participant data
por: Burgess, Stephen, et al.
Publicado: (2013)

Industry-Sponsored Research: Author's Reply
por: Sotelo, Julio
Publicado: (2006)

The Authors' Reply
por: Carrat, Fabrice, et al.
Publicado: (2022)

Reply to Jha
por: Montani, David, et al.
Publicado: (2022)

Blockchain protocols in clinical trials: Transparency and traceability of consent
por: Benchoufi, Mehdi, et al.
Publicado: (2018)

Risk of bias in observational studies using routinely collected data of comparative effectiveness research: a meta-research study
por: Nguyen, Van Thu, et al.
Publicado: (2021)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Undertaking Research in Other Countries: Author's Reply
por: Skene, Loane
Publicado: (2007)

Research Ethics Committees in Africa: Authors' Reply
por: Kass, Nancy E, et al.
Publicado: (2007)

COVID-19 research in LMICs – Authors' reply
por: Torres, Irene, et al.
Publicado: (2021)

Evaluating mortality in intensive care units: contribution of competing risks analyses
por: Resche-Rigon, Matthieu, et al.
Publicado: (2006)

Early non-invasive ventilation for acute respiratory failure in immunocompromised patients (IVNIctus): study protocol for a multicenter randomized controlled trial
por: Lemiale, Virginie, et al.
Publicado: (2014)

Evaluation of the Propensity score methods for estimating marginal odds ratios in case of small sample size
por: Pirracchio, Romain, et al.
Publicado: (2012)

Avoidable waste of research related to inadequate methods in clinical trials
por: Yordanov, Youri, et al.
Publicado: (2015)

Reply to Filteau
por: Newell, Marie-Louise, et al.
Publicado: (2011)

Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS
por: Legriel, Stephane, et al.
Publicado: (2016)

Research Ethics Boards: Reply from Ezekiel Emanuel
por: Emanuel, Ezekiel J
Publicado: (2006)

Reply to Chen et al.
por: Solelhac, Geoffroy, et al.
Publicado: (2023)

Multiple imputation for cause-specific Cox models: Assessing methods for estimation and prediction
por: Bonneville, Edouard F, et al.
Publicado: (2022)

Reply to Pawaskar et al.
por: Akpo, E I Hervé, et al.
Publicado: (2021)

The approach to informed consent in acute care research – Authors' reply
por: Casey, Jonathan D, et al.
Publicado: (2022)

Reply to: Gaudry et al.
por: Mekontso Dessap, Armand, et al.
Publicado: (2023)

Complex systems approach to scientific publication and peer-review system: development of an agent-based model calibrated with empirical journal data
por: Kovanis, Michail, et al.
Publicado: (2015)

Differential Globalization of Industry- and Non-Industry–Sponsored Clinical Trials
por: Atal, Ignacio, et al.
Publicado: (2015)

The Global Burden of Journal Peer Review in the Biomedical Literature: Strong Imbalance in the Collective Enterprise
por: Kovanis, Michail, et al.
Publicado: (2016)

Evaluating alternative systems of peer review: a large-scale agent-based modelling approach to scientific publication
por: Kovanis, Michail, et al.
Publicado: (2017)

Reply: ‘The importance of study design in the application of artificial intelligence methods in medicine’
por: Nagpal, Kunal, et al.
Publicado: (2019)

[From lifestyle to stimulation for dementia prevention in Brazil] – Authors’ reply
por: Borelli, Wyllians Vendramini, et al.
Publicado: (2022)

Research Ethics Boards: Reply from Trudo Lemmens and Carl Elliott
por: Lemmens, Trudo, et al.
Publicado: (2006)

Reply to Kuek et al.: Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease
por: Burgel, Pierre-Régis, et al.
Publicado: (2021)

Reply to Lipworth and Chan
por: Ambrose, Christopher S., et al.
Publicado: (2023)

Do simple screening statistical tools help to detect reporting bias?
por: Pirracchio, Romain, et al.
Publicado: (2013)

Simple screening statistical tools to detect reporting bias: when should we ask for raw data?
por: Pirracchio, Romain, et al.
Publicado: (2013)

Reply
por: Abdelrahman, Tamer, et al.
Publicado: (2015)

Reply
por: Moseley, G. Lorimer, et al.
Publicado: (2015)

Reply
por: Vowles, Kevin E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m832aq1udag0shfio9htt36q48